World's Best Scientists 2026 revealed!
Gareth J. Morgan

Gareth J. Morgan

D-Index & Metrics

Medicine

D-Index
135
Citations
86830
World Ranking
2028
National Ranking
1150

Overview

Gareth J. Morgan is affiliated with Boston University in the United States and has made extensive contributions to the fields of medicine and biochemistry, genetics, and molecular biology. Their research emphasizes hematology, molecular biology, oncology, cancer research, and genetics with a strong focus on multiple myeloma and related disorders.

The scientist's main research topics include multiple myeloma research and treatments, protein degradation and inhibitors, cancer genomics and diagnostics, peptidase inhibition and analysis, cancer treatment and pharmacology, cancer mechanisms and therapy, and ubiquitin and proteasome pathways.

Frequent publication venues for their work include:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Leukemia

Prominent papers that reflect their research contributions are:

  • International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM), 2020, Blood Cancer Journal
  • Localizing the Sustainable Development Goals Through the Lens of Urban Resilience: Lessons and Learnings from 100 Resilient Cities and Cape Town, 2020, Sustainability
  • Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma, 2021, Blood Advances
  • The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma, 2021, Nature Communications
  • Revealing the Impact of Structural Variants in Multiple Myeloma, 2020, Blood Cancer Discovery

Collaborations have been established with several researchers, notably Faith E. Davies, Francesco Maura, Ola Landgren, Eileen M. Boyle, and Brian A. Walker, who are frequent co-authors and have contributed extensively alongside Morgan.

Best Publications

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

    J J M van Dongen;A W Langerak;M Brüggemann;P A S Evans

  • The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report

    Boyd A Swinburn;Boyd A Swinburn;Vivica I Kraak;Steven Allender;Vincent J Atkins

  • High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

    J. Anthony Child;Gareth J. Morgan;Faith E. Davies;Roger G. Owen

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst

  • Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.

    Faith E. Davies;Noopur Raje;Noopur Raje;Noopur Raje;Teru Hideshima;Teru Hideshima;Teru Hideshima;Suzanne Lentzsch;Suzanne Lentzsch;Suzanne Lentzsch

  • International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

    R Fonseca;P L Bergsagel;J Drach;J Shaughnessy

  • The genetic architecture of multiple myeloma

    Gareth J. Morgan;Brian A. Walker;Faith E. Davies

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults

    Christine F. Skibola;Martyn T. Smith;Eleanor Kane;Eve Roman

  • First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

    Gareth J Morgan;Faith E Davies;Walter M Gregory;Kim Cocks

  • Images of organization, 2nd ed.

    Gareth Morgan

  • Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

    Brian A. Walker;Eileen M. Boyle;Christopher P. Wardell;Alex Murison

  • In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

    Panagiotis D Kottaridis;Donald W Milligan;Rajesh Chopra;Ronjon Chakraverty

  • Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party

    Bradley M. Augustson;Gulnaz Begum;Janet A. Dunn;Nicola J. Barth

  • Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.

    Brian G M Durie;Robert A. Kyle;Andrew Belch;William Bensinger

Frequent Co-Authors

Faith E. Davies
Faith E. Davies New York University Langone Medical Center
Brian A Walker
Brian A Walker Indiana University – Purdue University Indianapolis
Graham Jackson
Graham Jackson University of Newcastle Australia
Walter M Gregory
Walter M Gregory University of Leeds
Mark T. Drayson
Mark T. Drayson University of Birmingham
Frits van Rhee
Frits van Rhee University of Arkansas for Medical Sciences
Maurizio Zangari
Maurizio Zangari University of Arkansas for Medical Sciences
Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Joshua Epstein
Joshua Epstein University of Arkansas for Medical Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and supplementary online degrees can expand your options in the medical field. Many students interested in healthcare find value in pursuing the cheapest rn to bsn online programs, which enable registered nurses to earn a bachelor's degree efficiently and affordably.

For those without a prior nursing background, there are accessible options such as online bsn programs for non nurses. These programs help career changers enter the nursing profession through flexible, online study paths.

Some students may wish to leap directly into advanced practice roles. If this is your goal, consider the convenience of direct msn programs online, designed for individuals without prior nursing degrees, offering a streamlined route to a master's qualification.

Not all medical careers require direct patient care. In-demand administrative paths, such as medical billing and coding, offer flexible training options. If financial aid is a concern, research medical billing and coding schools that accept fafsa to support your education goals.

Best Scientists Citing Gareth J. Morgan

Trending Scientists

Recently Published Articles